Skip to content
healthcare.dev

UP and UP Daytime Childrens Multi Symptom Cold

NDC 82442-694, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride, suspension, from Target Corporation.

Product NDC
82442-694
Status
Listed
Labeler
Target Corporation
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82442-694 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEXTROMETHORPHAN HYDROBROMIDE5 mg/5mL
  • GUAIFENESIN100 mg/5mL
  • PHENYLEPHRINE HYDROCHLORIDE2.5 mg/5mL

Pharmacologic classes

Adrenergic alpha1-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]; alpha-1 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
82442-694-04824420694041 BOTTLE in 1 CARTON (82442-694-04) / 118 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 82442-694 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82442-694 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82442-694. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.